Bing Zou Selected Research

Bing Zou Research Topics

Disease

33	Neoplasms (Cancer) 02/2024 - 11/2003
14	Colonic Neoplasms (Colon Cancer) 01/2011 - 02/2005
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 07/2019
6	Carcinogenesis 01/2011 - 11/2003
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2024 - 01/2018
5	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2011
4	Pneumonia (Pneumonitis) 02/2024 - 05/2021
4	Esophageal Neoplasms (Esophageal Cancer) 08/2023 - 01/2020
4	Inflammation (Inflammations) 06/2023 - 03/2009
4	Stomach Neoplasms (Stomach Cancer) 09/2010 - 11/2003
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2009 - 09/2006
3	Hypoxia (Hypoxemia) 04/2022 - 10/2017
3	Infections 01/2021 - 09/2009
2	Sarcoidosis (Schaumann Disease) 08/2023 - 01/2020
2	Radiation Pneumonitis 01/2023 - 05/2021
2	Adenocarcinoma of Lung 01/2023 - 01/2022
2	Shock 04/2021 - 02/2006
2	Myocardial Infarction 01/2021 - 10/2016
2	Nonsyndromic Deafness 01/2020 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2018 - 03/2006
2	Ulcer 01/2017 - 10/2015
2	Deafness (Deaf Mutism) 01/2017 - 01/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2016 - 01/2015
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 02/2024
1	Thyroid Neoplasms (Thyroid Cancer) 01/2024
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2023
1	Esophageal Squamous Cell Carcinoma 08/2023
1	Pulmonary Sarcoidosis 08/2023
1	Sepsis (Septicemia) 06/2023
1	Lymphopenia (Lymphocytopenia) 06/2023
1	Colitis 02/2023
1	Drug Resistant Epilepsy 01/2023
1	Cardiac Arrhythmias (Arrythmia) 04/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Thymoma (Thymic Carcinoma) 01/2022
1	Esophagitis 05/2021
1	Hypertension (High Blood Pressure) 04/2021
1	Nephrolithiasis 04/2021
1	Urolithiasis 04/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 11/2020

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2017 - 03/2006
8	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2021
8	LigandsIBA 03/2010 - 06/2008
7	X-Linked Inhibitor of Apoptosis ProteinIBA 10/2012 - 03/2006
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2018
5	PPAR gammaIBA 06/2009 - 06/2008
4	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 10/2017 - 03/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 09/2010
3	SurvivinIBA 03/2010 - 11/2003
3	Troglitazone (Rezulin)FDA Link 09/2008 - 06/2008
2	PlatinumIBA 02/2024 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 02/2024 - 09/2009
2	Programmed Cell Death 1 ReceptorIBA 08/2023 - 01/2023
2	Bevacizumab (Avastin)FDA Link 01/2023 - 07/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2021
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2020 - 09/2009
2	Phosphotransferases (Kinase)IBA 10/2017 - 09/2006
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017 - 03/2006
2	Cadherins (E-Cadherin)IBA 01/2011 - 09/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 09/2009
2	Caspase 3 (Caspase-3)IBA 03/2010 - 09/2009
2	Therapeutic UsesIBA 09/2009 - 02/2005
2	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 02/2009 - 03/2006
2	Rosiglitazone (Avandia)FDA Link 01/2009 - 06/2008
2	InterferonsIBA 02/2008 - 03/2006
1	Indicators and Reagents (Reagents)IBA 01/2024
1	Retinaldehyde (Retinal)IBA 09/2023
1	sintilimabIBA 08/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2023
1	LipopolysaccharidesIBA 06/2023
1	tectorigeninIBA 06/2023
1	130-nm albumin-bound paclitaxelIBA 06/2023
1	ginsenoside Rg3IBA 02/2023
1	InflammasomesIBA 02/2023
1	brigatinibIBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	LuciferasesIBA 04/2022
1	RNA Precursors (Precursor, mRNA)IBA 04/2022
1	Competitive Endogenous RNAIBA 04/2022
1	Circular RNAIBA 04/2022
1	Purinergic Receptors (Receptors, Purine)IBA 01/2022
1	tryptamine N-methyltransferase (amine N-methyltransferase)IBA 01/2022
1	anlotinibIBA 01/2022
1	CateninsIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Cytochrome P-450 CYP2C19IBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 11/2020

Therapy/Procedure

8	Radiotherapy 02/2024 - 07/2019
7	Immunotherapy 02/2024 - 01/2021
7	Therapeutics 02/2024 - 01/2009
6	Drug Therapy (Chemotherapy) 02/2024 - 07/2019
2	Cranial Irradiation 06/2023 - 01/2018
2	Chemoradiotherapy 05/2023 - 07/2019
1	Lymph Node Excision (Lymph Node Dissection) 01/2024
1	Orchiectomy (Orchidectomy) 01/2024
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 04/2021